Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report

Overview of attention for article published in Frontiers in endocrinology, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 30 X posts from 28 X users, with an upper bound of 191,476 followers.

RT @angryhacademic: Case report: Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report https…

RT @angryhacademic: Case report: Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report https…

RT @angryhacademic: Case report: Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report https…

Case report: Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report https://t.co/MT2O4o8wNG

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 26 additional X posts.